← Browse by Condition
Medical Condition

postpartum hemorrhage

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for postpartum hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — postpartum hemorrhage Clinical Trials

How many clinical trials are currently recruiting for postpartum hemorrhage?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for postpartum hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for postpartum hemorrhage?
postpartum hemorrhage research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a postpartum hemorrhage clinical trial?
Eligibility criteria for postpartum hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
University Hospital, Bordeaux 1 trial
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 1 trial
Rambam Health Care Campus 1 trial

Recruiting Clinical Trials

NCT04304625 Phase 3
Recruiting
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Enrollment
1,380 pts
Location
France
Sponsor
University Hospital, Bordeaux
View Trial →
NCT06285396
Recruiting
Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
Enrollment
96 pts
Location
Canada
Sponsor
Samuel Lunenfeld Research Inst...
View Trial →
NCT07714902
Recruiting
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery
Enrollment
710 pts
Location
Israel
Sponsor
Rambam Health Care Campus
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology